Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Mon, 25 Sep 17 18:57:14 +0000 Mon, 25 Sep 17 18:57:14 +0000 FDA Rejects Abuse-Deterrent OxyContin http://www.pharmacytimes.com/product-news/fda-rejects-abusedeterrent-oxycontin http://www.pharmacytimes.com/product-news/fda-rejects-abusedeterrent-oxycontin Officials with the FDA have rejected Intellipharmaceutics&rsquo; abuse-deterrent Oxycodone Hydrochloride Extended-Release Tablets (Rexista), the company announced in a press release. Mon, 25 Sep 17 17:59:00 +0000 FDA: More Data Needed on RA Treatment http://www.pharmacytimes.com/news/fda-more-data-needed-on-ra-treatment http://www.pharmacytimes.com/news/fda-more-data-needed-on-ra-treatment Fri, 22 Sep 17 21:09:00 +0000 FDA Alert: Reduce Risks of Combined Use of Opioid Addiction Medications and CNS Depressants http://www.pharmacytimes.com/news/fda-alert-reduce-risks-of-combined-use-of-opioid-addiction-medications-and-cns-depressants http://www.pharmacytimes.com/news/fda-alert-reduce-risks-of-combined-use-of-opioid-addiction-medications-and-cns-depressants FDA officials have issued a drug safety communication advising that buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other central nervous system (CNS) depressants. Thu, 21 Sep 17 15:43:00 +0000 How Will Pharmacists Practice in 2015: A 2017 Response http://www.pharmacytimes.com/news/how-will-pharmacists-practice-in-2015-a-2017-response- http://www.pharmacytimes.com/news/how-will-pharmacists-practice-in-2015-a-2017-response- Pharmacists must continue to evolve to the needs of their patients and always remain a key player in health care decisions.<br /> &nbsp; Thu, 21 Sep 17 07:58:00 +0000 Opioid-Related Adverse Effects A Growing Problem for US Children http://www.pharmacytimes.com/news/opioidrelated-adverse-effects-a-growing-problem-for-us-children http://www.pharmacytimes.com/news/opioidrelated-adverse-effects-a-growing-problem-for-us-children Opioid-associated problems have become increasingly prevalent in children. Wed, 20 Sep 17 14:23:00 +0000 FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD http://www.pharmacytimes.com/product-news/fda-approves-first-oncedaily-single-inhaler-triple-therapy-for-copd http://www.pharmacytimes.com/product-news/fda-approves-first-oncedaily-single-inhaler-triple-therapy-for-copd Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Tue, 19 Sep 17 17:12:00 +0000 FDA Approves 'Next-Generation' Spinal Cord Stimulator for Chronic Pain Management http://www.pharmacytimes.com/product-news/fda-approves-nextgeneration-spinal-cord-stimulator-for-chronic-pain-management http://www.pharmacytimes.com/product-news/fda-approves-nextgeneration-spinal-cord-stimulator-for-chronic-pain-management Medtronic&#39;s Intellis platform can record and track patient activity all day and is managed on the Samsung Galaxy Tab S2 tablet interface. Mon, 18 Sep 17 21:06:00 +0000 FDA Approves Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women http://www.pharmacytimes.com/product-news/fda-approves-oral-granules-for-the-treatment-of-bacterial-vaginosis-in-adult-women http://www.pharmacytimes.com/product-news/fda-approves-oral-granules-for-the-treatment-of-bacterial-vaginosis-in-adult-women The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g. Mon, 18 Sep 17 16:31:00 +0000 FDA OKs ADHD Medication http://www.pharmacytimes.com/product-news/fda-oks-adhd-medication http://www.pharmacytimes.com/product-news/fda-oks-adhd-medication Fri, 15 Sep 17 16:47:00 +0000 FDA OKs Prescription-only App to Help Patients with Substance Use Disorders http://www.pharmacytimes.com/product-news/fda-oks-prescriptiononly-app-to-help-patients-with-substance-use-disorders http://www.pharmacytimes.com/product-news/fda-oks-prescriptiononly-app-to-help-patients-with-substance-use-disorders Data showed a statistically significant increase in adherence to abstinence for the patients with alcohol, cocaine, marijuana and stimulant SUD in those who used Reset, 40.3%, compared to the patients who did not, 17.6%. Fri, 15 Sep 17 15:22:00 +0000 FDA OKs Follicular Lymphoma Treatment http://www.pharmacytimes.com/news/fda-oks-follicular-lymphoma-medication http://www.pharmacytimes.com/news/fda-oks-follicular-lymphoma-medication Further clinical trials are required to confirm Aliqopa&rsquo;s clinical benefit, and the sponsor is conducting these studies. Thu, 14 Sep 17 18:53:00 +0000 FDA Approves First Biosimilar Cancer Treatment http://www.pharmacytimes.com/news/fda-approves-first-biosimilar-cancer-treatment http://www.pharmacytimes.com/news/fda-approves-first-biosimilar-cancer-treatment New biosimilars could play an important role in helping spur competition that can lower health care costs and increase access to important therapies. Thu, 14 Sep 17 18:12:00 +0000 5 New FDA Approvals to Know from August 2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-august-2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-august-2017 Learn about the new products and expanded indications approved by the FDA in August 2017. Thu, 14 Sep 17 14:28:00 +0000 FDA Panel Backs Herpes Zoster Vaccine Safety Data http://www.pharmacytimes.com/news/fda-panel-backs-herpes-zoster-vaccine-safety-data http://www.pharmacytimes.com/news/fda-panel-backs-herpes-zoster-vaccine-safety-data The candidate vaccine is a nonlive, recombinant subunit vaccine to help prevent herpes zoster and its complications, such as postherpetic neuralgia, in adults 50 and older.&nbsp; Wed, 13 Sep 17 20:33:00 +0000 FDA: Tentative OK for Admelog http://www.pharmacytimes.com/news/fda-tentative-ok-for-admelog http://www.pharmacytimes.com/news/fda-tentative-ok-for-admelog FDA officials noted that the human insulin analog met all necessary regulatory requirements for approval, but the approval is tentative pending any patent issues that are yet to be resolved.<br /> &nbsp; Fri, 01 Sep 17 19:21:00 +0000 FDA Approves Mylotarg for AML Treatment http://www.pharmacytimes.com/news/fda-approves-mylotarg-for-aml-treatment http://www.pharmacytimes.com/news/fda-approves-mylotarg-for-aml-treatment Fri, 01 Sep 17 19:05:00 +0000 FDA Approves Tisagenlecleucel in ALL as First Approved Gene Therapy http://www.pharmacytimes.com/product-news/fda-approves-tisagenlecleucel-in-all-as-first-approved-gene-therapy http://www.pharmacytimes.com/product-news/fda-approves-tisagenlecleucel-in-all-as-first-approved-gene-therapy Officials with the FDA have issued a historic approval of the first Chimeric Antigen Receptor (CAR) T-Cell Therapy to be available in the United States.&nbsp; Wed, 30 Aug 17 15:47:00 +0000 MDMA Designated 'Breakthrough' Drug for PTSD http://www.pharmacytimes.com/news/mdma-designated-breakthrough-drug-for-ptsd http://www.pharmacytimes.com/news/mdma-designated-breakthrough-drug-for-ptsd In MAPS&#39; completed phase 2 trials with 107 participants, 61% no longer qualified for PTSD after 3 sessions of MDMA-assisted psychotherapy 2 months following treatment. Wed, 30 Aug 17 14:54:00 +0000 FDA Grants Accelerated Approval to Chagas Disease Treatment http://www.pharmacytimes.com/news/fda-grants-accelerated-approval-of-chagas-disease-treatment http://www.pharmacytimes.com/news/fda-grants-accelerated-approval-of-chagas-disease-treatment &nbsp;It is the first treatment approved in the United States for the treatment of Chagas disease.<br /> &nbsp; Tue, 29 Aug 17 21:20:00 +0000 FDA Approves Antibacterial Drug for Complicated Urinary Tract Infections http://www.pharmacytimes.com/product-news/fda-approves-antibacterial-drug-for-complicated-urinary-tract-infections http://www.pharmacytimes.com/product-news/fda-approves-antibacterial-drug-for-complicated-urinary-tract-infections Officials with the FDA have announced the approval of Vabomere (Rempex) for the treatment of complicated urinary tract infections (cUTI). Tue, 29 Aug 17 21:06:00 +0000 Antirheumatic Biosimilar Gets FDA Nod http://www.pharmacytimes.com/news/antirheumatic-biosimilar-gets-fda-nod http://www.pharmacytimes.com/news/antirheumatic-biosimilar-gets-fda-nod Boehringer said they also plan to seek approval for an auto-injector of the biosimilar to expand options for patients. Tue, 29 Aug 17 15:56:00 +0000 Gilead Sciences Set to Acquire CAR-T Developer Kite Pharma http://www.pharmacytimes.com/news/gilead-sciences-set-to-acquire-cart-developer-kite-pharma http://www.pharmacytimes.com/news/gilead-sciences-set-to-acquire-cart-developer-kite-pharma Kite&#39;s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), is a CAR T therapy currently under priority review by the&nbsp;US FDA, and is expected to be a treatment option for refractory aggressive non-Hodgkin lymphoma, Mon, 28 Aug 17 17:26:00 +0000 FDA Approves Diabetes Drug Indication to Reduce CV Risk http://www.pharmacytimes.com/product-news/fda-approves-diabetes-drug-indication-to-reduce-cv-risk http://www.pharmacytimes.com/product-news/fda-approves-diabetes-drug-indication-to-reduce-cv-risk Officials with the FDA have approved a new indication for liraglutide (Victoza, Novo Nordisk). Fri, 25 Aug 17 15:58:00 +0000 CDC: Epilepsy Rates Increasing Among Adults, Children http://www.pharmacytimes.com/news/cdc-epilepsy-rates-increasing-among-adults-children http://www.pharmacytimes.com/news/cdc-epilepsy-rates-increasing-among-adults-children For the first time, epilepsy rate estimates have been available for every state, totaling in at least 3.4 million individuals living with the disorder. Wed, 23 Aug 17 14:51:00 +0000 FDA Approves Generic Cymbalta Capsules http://www.pharmacytimes.com/product-news/solco-healthcare-us-announces-the-approval-of-generic-cymbalta-capsules-in-the-united-states http://www.pharmacytimes.com/product-news/solco-healthcare-us-announces-the-approval-of-generic-cymbalta-capsules-in-the-united-states Tue, 22 Aug 17 17:20:00 +0000